There is a significant correlation between the activity of the PI3K/AKT signalling pathway and the progression of different cancers including gastric, breast, ovarian, prostate, colorectal, glioblastoma, and endometrial cancers.6 This evidence concerns the gene AKT1 and glioblastoma.